Hydrogen Inhalation and Blood Pressure — What a Hypertension RCT Showed

A 2022 randomised, placebo-controlled trial in Frontiers in Pharmacology tested daily low-dose hydrogen-oxygen inhalation in midlife and older adults with hypertension already on standard care. The hydrogen group showed significantly greater reductions in systolic and diastolic blood pressure than placebo, with a clean safety profile.